Etiology
Worldwide, three major meningeal pathogens (Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae) account for the majority of cases, but the proportion caused by each organism is somewhat variable by region and age.
Haemophilus spp. are small, gram-negative, pleomorphic coccobacilli that are either encapsulated or unencapsulated. Encapsulated strains are classified into six types, designated
a through
f. Nearly all invasive
H. influenzae infections are caused by serotype b (
Hib).
Hib strains have been further classified according to their outer membrane proteins (OMPs), which are useful for epidemiologic studies. Presently, almost all invasive disease worldwide is caused by nine clones of
Hib, although nontypeable
H. influenzae may rarely cause meningitis.
Neisseria spp. are non-spore-forming, nonmotile, kidneyshaped, gram-negative cocci that often appear in pairs (diplococci). Meningococci are classified by serogroups, which have important epidemiologic and prevention-related implications. Although 13 serogroups are recognized, most meningococcal disease is caused by organisms in serogroups A, B, C, Y, and W135. The virulence of meningococci is determined by their capsular polysaccharide, pili, immunoglobulin (Ig) A protease, lipopolysaccharide (endotoxin), OMPs, and outer membrane vesicles. All isolates from invasive infections are encapsulated (serogroup positive), whereas 20%-90% of those isolated from carriers are unencapsulated (nontypeable).
Pneumococci are non-spore-forming, nonmotile, small, gram-positive streptococci that are generally seen in pairs or chains. They are classified into serotypes on the basis of antigenic differences among capsular polysaccharides, which are essential for pneumococcal virulence. Approximately 90 pneumococcal serotypes have been characterized; however, only some of these cause invasive pneumococcal infections. Capsular types 1, 4, 6, 9, 14, 18, 19, and 23 cause ˜85% of serious infections in children, a pattern different from that observed in adults. The serotypes that cause meningitis have a strong correlation with those that cause pneumonia and bacteremia.
Gram-negative bacilli can also be implicated in meningitis. Most cases of neonatal meningitis and sepsis due to gramnegative bacilli are caused by Escherichia coli strains that bear the K1 capsular polysaccharide antigen, a marker of neurovirulence. In addition to the K1 capsule, many other potential virulence factors for meningitis have been documented. Gramnegative bacterial meningitis in children beyond the neonatal period is generally nosocomial or may be associated with other conditions, such as gut infections, head trauma, neurosurgical procedures, and immunodeficiency. Other Enterobacteriaceae can cause meningitis, including Klebsiella, Salmonella, Enterobacter, and Pseudomonas spp.
Group B streptococci are the most common cause of invasive neonatal disease in many countries. They are classified into six main serotypes; type III is responsible for most cases of neonatal meningitis. A decrease in the incidence of neonatal invasive group B streptococcal disease has been seen in developed countries, secondary to treatment of pregnant women with vaginal colonization at the time of delivery.
Listeria monocytogenes is a gram-positive, non-sporeforming, catalase-positive, aerobic rod. An important cause of neonatal meningitis, its source is generally the genital tract infection of the mother. However, nosocomial infection may also occur, particularly in low-birth-weight babies in longterm intensive care.
Staphylococci are gram-positive organisms that are generally seen in pairs or clusters.
Staphylococcus aureus is a virulent organism that is coagulase positive and causes pneumonia, sepsis, endocarditis, osteomyelitis, and meningitis. It is generally seen in malnourished children with staphylococcal skin lesions, dermal sinuses, or
CSF shunts. Secondary meningitis may also be seen in children with head trauma, neurosurgical procedures, or sinusitis.
Anaerobic meningitis may occur in certain conditions, such as rupture of brain abscess; chronic otitis, mastoiditis, or sinusitis; head trauma; neurosurgical procedures; congenital dural defects; gastrointestinal disease; suppurative pharyngitis;
CSF shunts; and immunosuppression.
Bacteroides fragilis,
Fusobacterium spp., and
Clostridium spp. are anaerobic pathogens that may cause meningitis.
Epidemiology
Hib remains the leading cause of bacterial meningitis in countries where
Hib vaccine has not been introduced, particularly in children <5 years of age, with an estimated incidence rate of 31 cases per 100,000 (
4). Approximately 80% of cases develop in unvaccinated children <2 years of age, and nearly all cases occur in children <5 years. Meningitis caused by
Hib in the first 2 months of life is rare, presumably because of placental transfer of protective maternal bactericidal antibodies. Natural immunity develops after 3 years of age, and concentrations of polyribosylribitol phosphate antibodies reach adult values by 7 years of age (
5). The two main factors that determine risk for disease are nasopharyngeal carriage and the concentration of circulating anticapsular antibody. High-risk factors for invasive
Hib infection include sickle cell anemia, asplenia,
CSF fistulas, and chronic pulmonary infections. If children >6 years have
Hib meningitis, such underlying conditions as otitis media, sinusitis,
CSF leaks, and immunodeficiency states, including splenectomy, should be excluded.
Meningococcal meningitis occurs primarily in children and young adults. A wide geographic variation exists between the serotypes of meningococci that are endemic and those that cause epidemics. In developed countries, most cases are due to serogroups B and C. However, serogroup A is responsible for large-scale epidemics in many developing countries, including Africa, India, Nepal, and Saudi Arabia. Age-specific incidence of meningococcal infection is inversely proportional to the presence of serum bactericidal antibodies against serogroups A, B, and C. More than 50% of infants possess bactericidal antibody at birth as a result of transplacental transfer; hence, meningococcal meningitis is rarely seen in the first 3 months of life. An intact complement system is also an important host defense against invasive meningococcal disease. Recurrent or chronic neisserial infections have been associated with rare isolated deficiencies of late complement components (C5, C6, C7, or C8, and perhaps C9) due to the role of complement in opsonophagocytosis. Deficiency or dysfunction of properdin, which is a stabilizing factor of C3 convertase in the alternate complement pathway, also predisposes to meningococcal infections. The time from nasopharyngeal acquisition to bloodstream invasion is short (usually 10 days). The incubation period may also be short, because “secondary” cases commonly occur within 1-4 days of the index case.
Pneumococcal meningitis occurs in all age groups, but maximum incidence rates are seen at the extremes of age with an estimated incidence rate of 17 cases per 100,000 population in children <5 years of age (
6). The common predisposing
factors include pneumonia, otitis media, sinusitis,
CSF fistulas or leaks, head injury, sickle cell disease, and thalassemia major.
Enterobacteriaceae, group B streptococci, and
Listeria cause meningitis predominantly in neonates. Enterobacteriaceae are normal gut flora, 25% of women are colonized with group B streptococci in the developed world, and may infect or colonize the female gastrointestinal tract, predominantly in the developing world. Aspiration of contaminated secretions, pneumonia, and hematogenous seeding of the meninges result in early-onset meningitis incidence of ˜10 per 100,000 (
7).
Vaccines against
Hib,
S. pneumoniae, and
N. meningitidis have decreased the disease burden by 99%, 94%, and 90%, respectively, in countries where vaccines are available. Due to the lack of vaccine availability worldwide, the global disease burden has been reduced by a mere 2%.
Pathogenesis
The development of childhood bacterial meningitis typically progresses through phases that include nasopharyngeal colonization and vascular invasion, meningeal invasion and multiplication in the subarachnoid space, induction and progression of inflammation in the subarachnoid space with associated pathophysiologic alterations, and damage to the
CNS.
Nasopharyngeal Colonization and Vascular Invasion
Most organisms that cause bacterial meningitis are transmitted by the respiratory route. They colonize the nasopharyngeal mucosa by adherence to the mucosal epithelium and evasion of mucosal host defense mechanisms. Adherence is mediated through adhesins on the bacterial surface that help surface binding to epithelial cell receptors and differs in various organisms. In N. meningitidis, adherence depends on the binding of fimbriae on the bacterial cell wall, whereas in S. pneumoniae, it depends mainly on the cell wall components. Host secretory IgA antibodies inhibit adherence and penetration of pathogens. The organisms secrete highly specific endopeptidases that cleave the heavy chains of secretory IgA and impair specific mucosal immunity, allowing the organisms to colonize.
Infection of the nasopharyngeal cells causes injury to the ciliated epithelial cells of the respiratory tract, resulting in loss of protective ciliary activity. Bacteria penetrate the mucosal barrier through either transepithelial or paraepithelial means. A number of bacterial factors help the process of invasion, including pili and lipo-oligosaccharides on the outer membranes of N. meningitidis and H. influenzae and the binding of S. pneumoniae to the polymeric immunoglobulin receptors on the mucosa. Pneumolysin and hyaluronidase of the pneumococci also facilitate mucosal invasion.
To survive in the bloodstream, the pathogens must overcome the host defense systems of circulating antibodies, complement-mediated bacterial killing, and neutrophil phagocytosis. The bacterial polysaccharide capsule operates against these mechanisms. In the absence of specific anticapsular antibodies, nonspecific activation of the alternative complement pathway is the main host defense against encapsulated bacteria. Persons with impaired alternative complement pathways and asplenia are at particular risk for overwhelming sepsis and meningitis by these encapsulated bacteria.
Meningeal Invasion
The blood-brain barrier (
BBB) normally protects against meningeal invasion. Penetration of
BBB occurs via microbial interactions with host receptors and depends on various neurotropic and virulence factors, including capsule characteristics, fimbriae, surface proteins of bacteria, and, perhaps, a critical magnitude of bacteremia.
After penetrating the meninges, the bacteria multiply freely in the
CSF, which has diminished host defense mechanisms. The bacterial capsular polysaccharides have high antiphagocytic properties, and the
CSF has a very low concentration of specific antibody. The bacteria thus multiply rapidly and spread over the entire surface of the brain and spinal cord along penetrating vessels.
Inflammation of the Subarachnoid Space
The multiplication and autolysis of bacteria in the
CSF lead to the release of bacterial components, including fragments of cell wall and lipopolysaccharide that trigger a strong inflammatory response in the subarachnoid space by inducing the production and release of inflammatory cytokines and chemokines. These cytokines can be produced by many brain cells, including astrocytes, glia, endothelial cells, ependymal cells, and macrophages. Early-response cytokines include
IL-1β, IL-6, and tumor necrosis factor (
TNF), which then trigger a cascade of inflammatory mediators, including other interleukins, chemokines, platelet-activating factor, matrix metalloproteinases, nitric oxide (
NO), and free oxygen radicals. The increase in cytokines enhances permeability of the
BBB and recruits leukocytes from the blood into
CSF, leading to
CSF pleocytosis. These mediators also affect
CBF and cerebral metabolism and contribute to the development of cerebral edema and neurologic sequelae.